DB15524ApprovedInvestigationalWithdrawnVaccines
Cyd dengue virus serotype 4 live (attenuated) antigen: Overview.
- First approval
- United States, 2019
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of September 01, 2026
Which companies are running trials of Cyd dengue virus serotype 4 live (attenuated) antigen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account